LPCN

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Lipocine Inc

NASDAQ | LPCN

3.27

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 20, 2025)

$18.77M

Market Cap

-

P/E Ratio

-1.1

EPS

$5.50

52 Week High

$2.52

52 Week Low

HEALTHCARE

Sector

LPCN Chart

Recent Chart
Price Action

LPCN Technicals

Tags:

LPCN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $11M
Total Revenue $11M
Cost Of Revenue $41K
Costof Goods And Services Sold $41K
Operating Income -$1.2M
Selling General And Administrative $5M
Research And Development $7.4M
Operating Expenses $12M
Investment Income Net -
Net Interest Income $1.1M
Interest Income $1.1M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $41K
Income Before Tax $9K
Income Tax Expense $681
Interest And Debt Expense -
Net Income From Continuing Operations $8.4K
Comprehensive Income Net Of Tax -
Ebit -$1.2M
Ebitda -$1.1M
Net Income $8.4K

Revenue & Profitability

Earnings Performance

LPCN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $23M
Total Current Assets $22M
Cash And Cash Equivalents At Carrying Value $6.2M
Cash And Short Term Investments $6.2M
Inventory -
Current Net Receivables $120K
Total Non Current Assets $189K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $15M
Other Current Assets $568K
Other Non Current Assets -
Total Liabilities $1.5M
Total Current Liabilities $1.5M
Current Accounts Payable $272K
Deferred Revenue -
Current Debt -
Short Term Debt $439K
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $439K
Other Current Liabilities $921K
Other Non Current Liabilities -
Total Shareholder Equity $21M
Treasury Stock -
Retained Earnings -$200M
Common Stock $8.9K
Common Stock Shares Outstanding $5.4M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$1.2M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $41K
Capital Expenditures $90K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $2.4M
Cashflow From Financing $209K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $8.4K

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $11M
Total Revenue $11M
Cost Of Revenue $41K
Costof Goods And Services Sold $41K
Operating Income -$1.2M
Selling General And Administrative $5M
Research And Development $7.4M
Operating Expenses $12M
Investment Income Net -
Net Interest Income $1.1M
Interest Income $1.1M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $41K
Income Before Tax $9K
Income Tax Expense $681
Interest And Debt Expense -
Net Income From Continuing Operations $8.4K
Comprehensive Income Net Of Tax -
Ebit -$1.2M
Ebitda -$1.1M
Net Income $8.4K

LPCN News

LPCN Profile

Lipocine Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Lipocine Inc. (LPCN) is an innovative clinical-stage biopharmaceutical company based in Salt Lake City, Utah, focused on developing advanced therapeutics for metabolic and endocrine disorders. The company’s proprietary drug delivery technologies underpin its promising pipeline, which aims to fulfill significant unmet needs in hormone replacement therapies. With its strong emphasis on scientific rigor and regulatory expertise, Lipocine is well-positioned to capitalize on emerging growth opportunities in the biopharmaceutical sector, making it a compelling investment prospect for institutional investors seeking to support transformative healthcare solutions.

LPTX
+368.57%
$2.05
SOND
+115.30%
$0.19
BNKK
+26.53%
$0.17
IVP
+29.03%
$0.13
VHAI
+100.00%
$0.00
NVDA
+3.91%
$193.82
AXDX
-61.36%
$0.03
WTO
-3.87%
$0.02
ADAP
-15.14%
$0.05
SGBX
+26.35%
$7.67
AUID
+34.25%
$2.17
IREN
-6.18%
$45.83
MNDR
+56.03%
$2.59
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
TSLA
+5.62%
$426.72
EXAS
+17.78%
$101.50
CIFR
+15.45%
$16.88
TWOH
-14.28%
$0.00
AFMD
-34.94%
$0.18
VSA
+3.00%
$0.17
WMT
+6.65%
$107.30
CHR
-7.13%
$0.05
SOFI
+6.53%
$28.46
AZI
-8.35%
$0.07
ASST
+4.76%
$1.10
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
PSTV
+4.97%
$0.51
BYND
-0.68%
$0.96
GOOGL
+3.55%
$303.23
LEN
-0.69%
$115.16
APLT
-4.49%
$0.28
VIVK
-4.96%
$0.12
KMI
-0.99%
$26.82
ONDS
-1.00%
$7.42
WULF
+13.73%
$13.91
EOSE
+6.65%
$13.63
SAND
-6.04%
$12.12
PLUG
+4.73%
$1.98
BITF
+9.72%
$2.85
DVLT
+18.05%
$1.88
PLTR
+2.89%
$170.21
SHOT
-74.37%
$0.39
INTC
+2.77%
$36.08
ZAPP
-46.30%
$0.15
SOUN
+10.40%
$12.84
ETHE
-5.77%
$24.16
APLD
+7.57%
$24.84
BBWI
-25.20%
$15.73
DIS
-1.51%
$104.67
BA
-2.07%
$185.70
BMNR
+1.17%
$29.52
AMZN
+1.87%
$226.86
TSM
+1.60%
$282.37
NEE
-0.43%
$84.27
IONZ
+1.56%
$5.07
AAPL
+1.94%
$273.79
GOOG
+4.10%
$305.01
MARA
+3.60%
$11.50
RGTI
+2.23%
$26.03
GM
+0.83%
$68.50
MU
-1.68%
$222.12
QUBT
+2.33%
$11.82
CRM
-2.40%
$227.88
VNET
-3.98%
$8.32
RZLV
+19.80%
$3.60
OSCR
-4.28%
$14.08
BURU
+1.85%
$0.21
TSLG
+1.47%
$8.25
JHX
+0.44%
$17.91
ABEV
-0.40%
$2.46
KDLY
-4.16%
$0.53
SNAP
+3.11%
$8.28
CRWV
+6.53%
$79.81
SFHG
-14.58%
$0.37
FL
-0.37%
$24.01
NBIS
+4.88%
$99.71
PFE
-0.74%
$24.69
CYPH
+3.91%
$3.05
ASBP
-2.21%
$0.09
NOK
+0.91%
$6.08
ACHR
+2.74%
$7.67
FHN
+2.69%
$21.32
AMD
+2.81%
$229.85
CWVX
+14.52%
$6.23
CLSK
+7.38%
$10.97
HOOD
+1.05%
$119.40
LOW
+4.02%
$228.41
VGFC
-1.90%
$0.05
ABBV
-0.41%
$232.91
PLTD
-3.60%
$6.95
TLRY
+4.46%
$1.00
NIO
+0.70%
$5.79
CCCS
+0.27%
$7.21
NVTS
+11.39%
$8.60
LPTX
+368.57%
$2.05
SOND
+115.30%
$0.19
BNKK
+26.53%
$0.17
IVP
+29.03%
$0.13
VHAI
+100.00%
$0.00
NVDA
+3.91%
$193.82
AXDX
-61.36%
$0.03
WTO
-3.87%
$0.02
ADAP
-15.14%
$0.05
SGBX
+26.35%
$7.67
AUID
+34.25%
$2.17
IREN
-6.18%
$45.83
MNDR
+56.03%
$2.59
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
TSLA
+5.62%
$426.72
EXAS
+17.78%
$101.50
CIFR
+15.45%
$16.88
TWOH
-14.28%
$0.00
AFMD
-34.94%
$0.18
VSA
+3.00%
$0.17
WMT
+6.65%
$107.30
CHR
-7.13%
$0.05
SOFI
+6.53%
$28.46
AZI
-8.35%
$0.07
ASST
+4.76%
$1.10
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
PSTV
+4.97%
$0.51
BYND
-0.68%
$0.96
GOOGL
+3.55%
$303.23
LEN
-0.69%
$115.16
APLT
-4.49%
$0.28
VIVK
-4.96%
$0.12
KMI
-0.99%
$26.82
ONDS
-1.00%
$7.42
WULF
+13.73%
$13.91
EOSE
+6.65%
$13.63
SAND
-6.04%
$12.12
PLUG
+4.73%
$1.98
BITF
+9.72%
$2.85
DVLT
+18.05%
$1.88
PLTR
+2.89%
$170.21
SHOT
-74.37%
$0.39
INTC
+2.77%
$36.08
ZAPP
-46.30%
$0.15
SOUN
+10.40%
$12.84
ETHE
-5.77%
$24.16
APLD
+7.57%
$24.84
BBWI
-25.20%
$15.73
DIS
-1.51%
$104.67
BA
-2.07%
$185.70
BMNR
+1.17%
$29.52
AMZN
+1.87%
$226.86
TSM
+1.60%
$282.37
NEE
-0.43%
$84.27
IONZ
+1.56%
$5.07
AAPL
+1.94%
$273.79
GOOG
+4.10%
$305.01
MARA
+3.60%
$11.50
RGTI
+2.23%
$26.03
GM
+0.83%
$68.50
MU
-1.68%
$222.12
QUBT
+2.33%
$11.82
CRM
-2.40%
$227.88
VNET
-3.98%
$8.32
RZLV
+19.80%
$3.60
OSCR
-4.28%
$14.08
BURU
+1.85%
$0.21
TSLG
+1.47%
$8.25
JHX
+0.44%
$17.91
ABEV
-0.40%
$2.46
KDLY
-4.16%
$0.53
SNAP
+3.11%
$8.28
CRWV
+6.53%
$79.81
SFHG
-14.58%
$0.37
FL
-0.37%
$24.01
NBIS
+4.88%
$99.71
PFE
-0.74%
$24.69
CYPH
+3.91%
$3.05
ASBP
-2.21%
$0.09
NOK
+0.91%
$6.08
ACHR
+2.74%
$7.67
FHN
+2.69%
$21.32
AMD
+2.81%
$229.85
CWVX
+14.52%
$6.23
CLSK
+7.38%
$10.97
HOOD
+1.05%
$119.40
LOW
+4.02%
$228.41
VGFC
-1.90%
$0.05
ABBV
-0.41%
$232.91
PLTD
-3.60%
$6.95
TLRY
+4.46%
$1.00
NIO
+0.70%
$5.79
CCCS
+0.27%
$7.21
NVTS
+11.39%
$8.60
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.